Premium
The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia
Author(s) -
Krass I.,
Armour C. L.,
Mitchell B.,
Brillant M.,
Dienaar R.,
Hughes J.,
Lau P.,
Peterson G.,
Stewart K.,
Taylor S.,
Wilkinson J.
Publication year - 2007
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.2007.02143.x
Subject(s) - medicine , pharmacy , diabetes mellitus , type 2 diabetes , intervention (counseling) , clinical pharmacy , community pharmacy , family medicine , physical therapy , nursing , endocrinology
Aim To assess the impact of a community pharmacy diabetes service model on patient outcomes in Type 2 diabetes. Methods The study utilized a multisite, control vs. intervention, repeated‐measures design within four states in Australia. Fifty‐six community pharmacies, 28 intervention and 28 control, were randomly selected from a representative sample of urban and rural areas. Intervention pharmacies delivered a diabetes service to patients with Type 2 diabetes, which comprised an ongoing cycle of assessment, management and review, provided at regular intervals over 6 months in the pharmacy. These services included support for self monitoring of blood glucose, education, adherence support, and reminders of checks for diabetes complications. Control pharmacists assessed patients at 0 and 6 months and delivered no intervention. Results A total of 289 subjects (149 intervention and 140 control) completed the study. For the intervention subjects, the mean blood glucose level decreased over the 6‐month study from 9.4 to 8.5 mmol/l ( P < 0.01). Furthermore, significantly greater improvements in glycaemic control were seen in the intervention group compared with the control: the mean reduction in HbA 1c in the intervention group was −0.97% (95% CI: −0.8, −1.14) compared with −0.27% (95% CI: −0.15, −0.39) in the control group. Improvements were also seen in blood pressure control and quality of life in the intervention group. Conclusion A pharmacy diabetes service model resulted in significant improvements in clinical and humanistic outcomes. Thus, community pharmacists can contribute significantly to improving care and health outcomes for patients with Type 2 diabetes. Future research should focus on clarifying the most effective elements of the service model.